Ginkgo Bioworks Holdings Inc
Change company Symbol lookup
Select an option...
DNA Ginkgo Bioworks Holdings Inc
$SMOVE3M ICE BofAML Swap MOVE 3-Month Index
BRCC BRC Inc
FSMAX Fidelity® Extended Market Index Fund
PFE Pfizer Inc
DUNE Dune Acquisition Corp
METV Roundhill Ball Metaverse ETF
TBNK Territorial Bancorp Inc
BAC Bank of America Corp
ICD Independence Contract Drilling Inc
Go

Company profile

Ginkgo Bioworks Holdings, Inc., formerly Spinning Eagle Acquisition Corp, is engaged in building a platform to program cells. The Company's platform is used to program cells on behalf of its customers. Its cell programs are designed to enable biological production of products such as therapeutics, key food ingredients, and chemicals derived from petroleum. The Company's platform is used to design, write, and debug deoxyribonucleic acid (DNA) code in engineered organisms to execute programs for its customers. The Company’s platform comprises of equipment, robotic automation, software, data pipelines and tools, and standard operating procedures for genetic engineering, fermentation, and analytics, a library of proprietary genetic assets and associated performance data; and developers and operators of the foundry and codebase. It serves industries, including chemicals, agriculture, food, consumer products, and pharmaceuticals.

Postmarket

Last Trade
Delayed
$2.79
0.05 (1.82%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$2.74
Day's Change
0.31 (12.76%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.84
Day's Low
2.42
Volume
(Heavy Day)
Volume:
35,904,185

10-day average volume:
24,964,301
35,904,185

Display:

Providers:

UpdateCancel
4 providers
March 25, 2022
Airport-based study found first U.S. case of BA.2 subvariant of omicron in December

By Ciara Linnane U.S. cases are rising in 11 states, and experts still predict another wave is coming An airport-based COVID-19 surveillance program detected the first known U.S. case of the highly transmissible omicron BA.2...(MarketWatch)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.